Xoma reported $85K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Ardelyx ARDX:US $ 0.01M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Celldex Therapeutics CLDX:US $ 0.05M 0.01M
Chimerix CMRX:US $ 0.09M 0M
Curis CRIS:US $ 0.92M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Emergent Biosolutions EBS:US $ 0.1M 0M
Epizyme EPZM:US $ 0.01M 0M
Life Technologies LIFE:US $ 0.03M 0.01M
Macrogenics MGNX:US $ 0.61M 0.01M
Novartis NVS:US $ 901M 12M
Novartis NOVN:VX SF 901M 12M
Prothena PRTA:US $ 0.46M 0.02M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Xoma XOMA:US $ 85K 0
YTE INCY:US $ 0.22M 0M